These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1712815)

  • 1. Activation of human neutrophils increases thrombospondin receptor expression.
    Suchard SJ; Boxer LA; Dixit VM
    J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin stimulates motility of human neutrophils.
    Mansfield PJ; Boxer LA; Suchard SJ
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3077-86. PubMed ID: 2269666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R; Lahav J
    Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carcinoma cells express receptors for distinct domains of thrombospondin.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Mar; 51(6):1645-50. PubMed ID: 1705477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of human neutrophils and HL-60 cells with the extracellular matrix.
    Suchard SJ
    Blood Cells; 1993; 19(2):197-221, discussion 221-3. PubMed ID: 7508769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil thrombospondin receptors are linked to GTP-binding proteins.
    Suchard SJ; Mansfield PJ
    J Cell Physiol; 1996 Jul; 168(1):217-27. PubMed ID: 8647918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thrombospondin receptor expression during HL-60 cell differentiation.
    Suchard SJ; Mansfield PJ; Dixit VM
    J Immunol; 1994 Jan; 152(2):877-88. PubMed ID: 7506739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophil adherence to thrombospondin occurs through a CD11/CD18-independent mechanism.
    Suchard SJ; Burton MJ; Dixit VM; Boxer LA
    J Immunol; 1991 Jun; 146(11):3945-52. PubMed ID: 1674522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin receptor expression in human neutrophils coincides with the release of a subpopulation of specific granules.
    Suchard SJ; Burton MJ; Stoehr SJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):513-20. PubMed ID: 1376114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil-like HL-60 cells.
    Mansfield PJ; Suchard SJ
    J Immunol; 1993 Mar; 150(5):1959-70. PubMed ID: 8436828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.
    Savill J; Hogg N; Ren Y; Haslett C
    J Clin Invest; 1992 Oct; 90(4):1513-22. PubMed ID: 1383273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36.
    Li WX; Howard RJ; Leung LL
    J Biol Chem; 1993 Aug; 268(22):16179-84. PubMed ID: 7688364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains.
    Yabkowitz R; Mansfield PJ; Dixit VM; Suchard SJ
    Cancer Res; 1993 Jan; 53(2):378-87. PubMed ID: 8417830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain.
    Yabkowitz R; Lowe JB; Dixit VM
    J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin.
    Takagi J; Fujisawa T; Usui T; Aoyama T; Saito Y
    J Biol Chem; 1993 Jul; 268(21):15544-9. PubMed ID: 8340381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of N-formyl-methionyl-leucyl-phenylalanine receptors on human neutrophils. Effects of isolation and temperature on receptor expression and functional activity.
    Tennenberg SD; Zemlan FP; Solomkin JS
    J Immunol; 1988 Dec; 141(11):3937-44. PubMed ID: 2846695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
    Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
    Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.